Vaccine

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.

What are Vaccines?

There are several diseases like Diphtheria, whooping cough (pertussis), measles, mumps, Yellow fever, small pox and German measles (rubella) that are unfamiliar to many these days.

Vaccine History

What is a Vaccine Breakthrough?

What are the Main Causes of Vaccine Hesitancy?

Investigating the Importance of Investing in Vaccine Manufacturing

Vaccine Schedule

Vaccine Effectiveness

Vaccination in Humanitarian Settings

Plant-Derived Vaccines

Vaccine Production

Vaccine Excipients

Vaccine Delivery

See more featured articles »

Vaccine Immunity

Hib Immunization

History of Vaccination

How are Vaccines Stored?

What are the Different Types of Vaccines?

What is a Subunit Vaccine?

What is an Inactivated Vaccine?

What is a Live-Attenuated Vaccine?

What is a Toxoid Vaccine?

What is an RNA Vaccine?

What is a DNA Vaccine?

What are Adenovirus-Based Vaccines?

What is a Non-Replicating Vaccine?

What is a VLP Vaccine?

What are Nanoparticle-Based Vaccines?

The Future of Vaccines

Insight into Personalized Vaccines

Could there be a Salmonella Vaccine?

Role of Computer Modeling in Vaccine Development

How Veterinary Vaccines Affect Human Health

A New Breed of Vaccine: Exploring Doggybone ™ DNA Technology

What is the Importance of Vaccination Coverage?

The Big Catch-Up: How the COVID-19 pandemic impacted vaccination coverage

Transforming Vaccine Design: The Promise of Systems Biology

What is Immunobridging?

Immunization strategies: What lessons can we learn from successful campaigns?

The Essential Program on Immunization is 50: Milestones, achievements, and future directions

Latest Vaccine News and Research

New approach to stabilize RSV protein could lead to better vaccines

In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can cause severe pneumonia and even death.

20 Nov 2024

Scientists discover brain circuit for voluntary breathing control

Deep breath in, slow breath out… Isn't it odd that we can self-soothe by slowing down our breathing?

20 Nov 2024

WHO grants Emergency Use Listing for LC16m8 mpox vaccine

The World Health Organization (WHO) has granted Emergency Use Listing (EUL) for the LC16m8 mpox vaccine, making it the second mpox vaccine to be supported by WHO following the Director-General's declaration of an mpox public health emergency of international concern (PHEIC) on 14 August 2024.

19 Nov 2024

New research links sphingolipids to heart disease and atherosclerosis

Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns.

19 Nov 2024

New nasal vaccine could help stop the spread of whooping cough

As whooping cough cases rise in the U.S., a new nasal vaccine developed by Tulane University may hold the key to reducing the spread of the highly contagious respiratory disease.

19 Nov 2024

Small Solutions for Big Problems in Drug Discovery and Delivery

Ijeoma Uchegbu discusses nanomedicine's role in improving medication adherence and developing non-addictive pain relief solutions at ELRIG Drug Discovery 2024.

19 Nov 2024

Electronic nudges boost flu vaccination rates among heart attack survivors

An electronic letter, or nudge, highlighting the cardiovascular benefits of influenza vaccines improved vaccination rates among more than 2 million adults—with a greater impact on those who have had a heart attack—across three clinical trials spanning the most-recent, two consecutive influenza seasons in Denmark.

18 Nov 2024

WHO leads global push for cervical cancer elimination

As world leaders arrive in Rio de Janeiro, Brazil, for the G20 Summit this weekend, the city's iconic Christ the Redeemer statue will be illuminated in the color teal.

18 Nov 2024

Neoantigen DNA vaccines improve survival and immunity in triple-negative breast cancer patients

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising immune responses and improved recurrence-free survival in high-risk triple-negative breast cancer patients.

17 Nov 2024

Are you falling for fake news? Age and analytical thinking might save you

Older adults and analytical thinkers excel at discerning true from false news, while ideological biases and political identity shape misinformation susceptibility in distinct ways.

17 Nov 2024

MEMPHIS system sheds light on vaccine response differences across ages

mRNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than did younger adults. Why? Boston Children's researchers, led by Byron Brook, PhD, and Ofer Levy, MD, PhD, have found some answers, while providing proof-of-concept of a new system that can model vaccine responses in a dish.

15 Nov 2024

Study finds artemisinin resistance in African children with severe malaria

Mutations in malarial parasites linked to artemisinin-resistance in Southeast Asia have now been found in African children hospitalised for complicated malaria, according to a new study presented at the Annual Meeting of the American Society of Tropical Medicine & Hygiene (ASTMH).

15 Nov 2024

Argonne receives $21.7 million to advance cancer and vaccine discoveries

The U.S. Department of Energy's (DOE) Argonne National Laboratory will use its world-leading capabilities in artificial intelligence (AI) and high performance computing to research novel ways to fight cancer and transform vaccine discovery.

15 Nov 2024

Measles outbreaks increase worldwide with inadequate immunization coverage

Worldwide, there were an estimated 10.3 million cases of measles in 2023, a 20% increase from 2022, according to new estimates from the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC). Inadequate immunization coverage globally is driving the surge in cases.

14 Nov 2024